These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 11808079

  • 1. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K, Itoh M, Shimada H.
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, Lee CG, Bridges K, Parrish RS, Henslee-Downey PJ.
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [Abstract] [Full Text] [Related]

  • 3. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
    Nagafuji K, Eto T, Hayashi S, Oshima K, Maeda Y, Gondo H, Inamura T, Niho Y.
    Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C, Kebaili K, Dijoud F, Basset T, Philippe N, Bertrand Y.
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 6. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B, Li DP, Xu KL, Pan XY.
    Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128
    [Abstract] [Full Text] [Related]

  • 7. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
    Iwami H, Misawa A, Tsunamoto K, Kasubuchi Y, Naya M, Hojo M, Goto T, Hibi S, Matsumura T, Todo S, Imashuku S.
    Rinsho Ketsueki; 1998 Mar 20; 39(3):198-204. PubMed ID: 9577643
    [Abstract] [Full Text] [Related]

  • 8. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK, deMagalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.
    Bone Marrow Transplant; 2003 Jan 20; 31(2):121-8. PubMed ID: 12621494
    [Abstract] [Full Text] [Related]

  • 9. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH, Chiang KY, McGuirk JP, Pati AR, Godder KT, Welsh JA, Waldron RL, McElveen JL, Henslee-Downey PJ.
    Bone Marrow Transplant; 1998 Feb 20; 21(3):295-7. PubMed ID: 9489654
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.
    Ohga S, Kanaya Y, Maki H, Takada H, Ohshima K, Kanda M, Nomura A, Suminoe A, Matsuzaki A, Hara T.
    Bone Marrow Transplant; 2000 Jan 20; 25(2):209-12. PubMed ID: 10673683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
    Aisa Y, Mori T, Nakazato T, Suzuki S, Suzuki N, Ikeda Y, Okamoto S.
    Transpl Infect Dis; 2009 Oct 20; 11(5):438-41. PubMed ID: 19497045
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
    Wang IJ, Lu MY, Chiang BL, Lin WC, Lin DT, Lin KH.
    Pediatr Blood Cancer; 2005 Sep 20; 45(3):340-3. PubMed ID: 15547918
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA, Vasef MA, Comito M, Gilman AL, Lee N, Ritchie J, Rumelhart S, Holida M, Goldman F.
    Bone Marrow Transplant; 2003 Sep 20; 32(5):527-33. PubMed ID: 12942101
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.
    McGuirk JP, Seropian S, Howe G, Smith B, Stoddart L, Cooper DL.
    Bone Marrow Transplant; 1999 Dec 20; 24(11):1253-8. PubMed ID: 10642818
    [Abstract] [Full Text] [Related]

  • 20. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
    Liu D, Tammik C, Zou JZ, Ernberg I, Masucci MG, Ringden O, Levitsky V.
    Clin Transplant; 2004 Oct 20; 18(5):518-24. PubMed ID: 15344953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.